Animal and clinical studies have evaluated statins, angiotensin-converting enzyme inhibitors/angiotensin-II receptor blockers, and corticosteroids for the treatment or prevention of AF.97 Further studies are required to reveal practical therapeutic approaches to control these biomarkers of inflammation, which could ultimately help to reduce the association of inflammation with AF. The gene discussed is ACE; the disease is atrial fibrillation.